← All sarcoma trials
Recruiting nowAges 18 Years to 99 Years

Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma

Sponsor: Azienda USL Reggio Emilia - IRCCS · NCT06749600 on ClinicalTrials.gov ↗

Conditions studied

Primary Ovarian Leiomyosarcoma

Where it's running10 sites

10 international sites
  • AOU Policlinico di Modena

    Modena, Italy, Italy 41125

    Recruiting now
    • Cinzia Baldessari, MD(contact)[email protected]
    • Cinzia Baldessari, MD(principal investigator)
  • Azienda Ospedaliero Universitaria di Parma - S.C. Ostetricia e Ginecologia

    Parma, PR, Italy 43126

    Recruiting now
  • Azienda USL IRCCS di Reggio Emilia

    Reggio Emilia, RE, Italy 42123

    Recruiting now
  • Malzoni - Avellino

    Avellino, Italy 83100

    Recruiting now
  • Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" - Catania

    Catania, Italy 95123

    Recruiting now
  • IRCCS Ospedale San Raffaele

    Milan, Italy 20132

    Recruiting now
  • Fondazione Irccs San Gerardo Dei Tintori

    Monza, Italy

    Recruiting now
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale

    Naples, Italy 80131

    Recruiting now
  • Università degli Studi di Napoli Federico II

    Naples, Italy

    Recruiting now
  • Ospedale "Sacro Cuore"

    Verona, Italy

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Diagnosis of primary leiomyosarcoma of the ovary;
* Patients diagnosed with POLMS for whom data relating to diagnosis and treatment are available.
* Aged between 18 and 99 years

Exclusion Criteria:

\- All patients with other forms of ovarian sarcoma (rhabdomyosarcomas, fibrosarcomas, stromal cell sarcomas) and patients diagnosed with leiomyosarcoma of the uterus will be excluded.

Updated 2026-05-05 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.